Bio-Rad Laboratories, Inc. (BIO) Social Stream



Bio-Rad Laboratories, Inc. (BIO): $495.62

4.24 (+0.86%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

BIO-RAD LABORATORIES INC (BIO) Price Targets From Analysts

Use the tables below to see what analysts covering BIO-RAD LABORATORIES INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-29 3 $950 $750 $876.666 $499.09 75.65%
2022-02-11 3 $930 $750 $820 $499.09 64.3%
2022-02-28 2 $930 $780 $855 $499.09 71.31%
2022-05-02 2 $930 $750 $820 $499.09 64.3%
2022-07-08 3 $930 $700 $776.666 $499.09 55.62%
2022-07-31 2 $700 $700 $700 $499.09 40.26%

The Trend in the Analyst Price Target


Over the past 46 weeks, BIO's average price target has gone down $156.25.

BIO reports an average of 27.62% for its upside potential over the past 48 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-02-11 3 930 750 820.000 629.80 30.2%
2022-02-28 2 930 780 855.000 625.96 36.59%
2022-05-02 2 930 750 820.000 501.42 63.54%
2022-07-08 2 700 700 700.000 517.12 35.37%
2022-07-08 3 930 700 776.666 517.12 50.19%

BIO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The Trend in the Broker Recommendations


BIO's average broker recommendation rating improved by 0 over the prior 25 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for BIO as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, BIO-RAD LABORATORIES INC's average analyst price target is greater than 695.07% of them.
  • BIO-RAD LABORATORIES INC's number of analysts covering the stock is greater than 7.42% of stocks in the large market cap category.
  • To contextualize these metrics, consider that out of Healthcare stocks, BIO-RAD LABORATORIES INC's variance in analysts' estimates is lower than -10.96% of them.
  • In the context of stocks in the large market cap category, BIO-RAD LABORATORIES INC's upside potential (average analyst target price relative to current price) is greater than 519.81% of them.

Stocks similar to BIO-RAD LABORATORIES INC in the Measuring and Control Equipment industry regarding analyst recommendations and price targets are AVTR, A, and KLAC.

Is BIO a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5786 seconds.